RIGEL PHARMACEUTICALS INC — Director's Dealing 2018

Sep 20, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2018-09-17

Reporting Person: Duliege Anne-Marie (EVP & Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-17	Common Stock	M	115500	$2.54	Acquired	115500	Direct
2018-09-17	Common Stock	S	115500	$3.50	Disposed	0	Direct
2018-09-17	Common Stock	M	37500	$2.11	Acquired	37500	Direct
2018-09-17	Common Stock	S	37500	$3.50	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-09-17	Employe Stock Option (right to buy)	$2.54	M	115500	Disposed	2026-05-05	Common Stock (115500)	Direct
2018-09-17	Employee Stock Option (right to buy)	$2.11	M	37500	Disposed	2027-02-02	Common Stock (37500)	Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018.

F2: One fourth (1/4th) of the option vests one (1) year from March 7, 2016 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months.

F3: The shares vest over four (4) years from January 1, 2017.